Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma

  • Ajai Chari, Sarah Larson, Beata Holkova, Robert F. Cornell, Cristina Gasparetto, Chatchada Karanes, Jeffrey V. Matous, Ruben Niesvizky, Jason Valent, Matthew Lunning, Saad Z. Usmani, Larry D. Anderson Jr, Lipo Chang, Yihua Lee, Yvonne Pak, Zeena Salman, Thorsten Graef, Elizabeth Bilotti, Saurabh Chhabra
  • Leukemia & Lymphoma, April 2018, Taylor & Francis
  • DOI: 10.1080/10428194.2018.1443337

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/10428194.2018.1443337